Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BY 4.0Frontiers in Pharmacology

Berbamine exerts anti-breast-cancer effects in association with autophagy-related responses and PI3K/Akt1/mTOR signaling

  • Rui Ma1
  • Lingchen Liao2
  • Gang Fang1,2
  • Jinlin Zheng3
  • Ziwei Xia3
  • Shuqi Chen4
  • Yuzhou Pang1,3
  • Zhiyong Cao3
4 affiliations
  1. 1Traditional Therapy Department, Guangdong Provincial Hospital of Chinese Medicine
  2. 2Guangxi Higher Education Key Laboratory for the Research of Du-related Diseases in Zhuang Medicine, Guangxi University of Chinese Medicine
  3. 3Institute of Traditional Chinese and Zhuang-Yao Ethnic Medicine, Guangxi University of Chinese Medicine
  4. 4Acupuncture Department, Guangdong Provincial Hospital of Chinese Medicine
Open at sourceDOICite

Abstract

Introduction: Breast cancer remains a leading cause of cancer-related morbidity and mortality worldwide, and effective, well-tolerated therapeutic strategies are needed. Berbamine (BBM), a natural bisbenzylisoquinoline alkaloid, has anticancer activity, but its effects on autophagy- and lysosome-related processes in breast cancer remain incompletely understood.

Methods: We evaluated the effects of BBM on MDA-MB-231, MDA-MB-468, MCF-7, and 4T1 breast cancer cells and normal mammary epithelial cells using assays of cell viability, migration, invasion, autophagy-related responses, lysosome-associated changes, immunofluorescence, transmission electron microscopy, and Western blotting. Exploratory network analysis was used to prioritize candidate BBM-associated pathways, and molecular docking was used to predict interactions between BBM and selected pathway proteins. Antitumor activity was further assessed in an MCF-7 xenograft model.

Results: BBM inhibited the proliferation, migration, and invasion of breast cancer cells while showing relatively low cytotoxicity toward normal mammary epithelial cells. BBM treatment was associated with increased levels of p-ULK1, ATG5, ATG7, and Beclin1, increased LC3 puncta, and accumulation of double-membraned autophagosomes. BBM was also associated with TFEB nuclear translocation, increased LAMP2 expression, and enhanced LysoTracker staining. Network analysis prioritized the PI3K/Akt signaling pathway, and molecular docking predicted potential interactions between BBM and PI3K, Akt1, and mTOR. Western blot analysis showed reduced phosphorylation of these proteins in cultured breast cancer cells. In the MCF-7 xenograft model, BBM inhibited tumor growth and was associated with changes in autophagy-related markers.

Discussion: These findings support the involvement of autophagy-related responses, lysosome-associated changes, and PI3K/Akt1/mTOR pathway modulation in the anti-breast-cancer effects of BBM, while further studies are needed to establish direct target engagement and causal relationships.

Related

  1. Exercise Is Associated with Skeletal Muscle Autophagy–Lysosome-Related Markers and Nrf2/ARF1 Signaling in HFD Mice
    Shujuan Hu, Xuan Liu, Ruohan Xia +1
    NutrientsPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMC
  2. SARS-CoV-2 ORF7a induces cytotoxicity associated with AP-1 signaling and ferroptosis-related responses
    Chia-Hsin Chen, Ru-Fang Li, Yi-Hsiu Wu +1
    Experimental and Molecular PathologyPeer-reviewedCC BYFull textInfectious diseaseDOAJ
  3. Dysregulated nitric oxide signaling and its association with arginase-2 and fatty acid synthase in obesity and related comorbidities
    Ahmed R. Taha, Hany M. El-Bassossy, Shereen Eassa +2
    Scientific ReportsPeer-reviewedCC BY 4.0Full textPhysiologyCrossref
  4. Astragaloside IV attenuates post-ischemic neuroinflammation associated with Treg-related regulation of CD86/CD206-associated brain myeloid phenotypic responses and PI3K/AKT signaling alterations
    Hengtong An, Shuhan Guo, Shaoze Yang +7
    Frontiers in immunologyPeer-reviewedCC BYFull textNeurologyEurope PMCCrossref
  5. A Non-Linear Ototoxic Response to Cisplatin Is Associated with Autophagy and PTEN/PI3K/AKT Signaling in Cochlear Hair Cells and Spiral Ganglion Neurons
    Yingru Li, Miaomiao Han, Cheng Lu +6
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{ma2026berbamine,
  title = {{Berbamine exerts anti-breast-cancer effects in association with autophagy-related responses and PI3K/Akt1/mTOR signaling}},
  author = {Rui Ma and Lingchen Liao and Gang Fang and Jinlin Zheng and Ziwei Xia and Shuqi Chen and Yuzhou Pang and Zhiyong Cao},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  month = oct,
  doi = {10.3389/fphar.2026.1976563},
  url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1976563/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Berbamine exerts anti-breast-cancer effects in association with autophagy-related responses and PI3K/Akt1/mTOR signaling
AU  - Rui Ma
AU  - Lingchen Liao
AU  - Gang Fang
AU  - Jinlin Zheng
AU  - Ziwei Xia
AU  - Shuqi Chen
AU  - Yuzhou Pang
AU  - Zhiyong Cao
PY  - 2026
DA  - 2026/10/29
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1976563
UR  - https://www.frontiersin.org/articles/10.3389/fphar.2026.1976563/full
AB  - Introduction: Breast cancer remains a leading cause of cancer-related morbidity and mortality worldwide, and effective, well-tolerated therapeutic strategies are needed. Berbamine (BBM), a natural bisbenzylisoquinoline alkaloid, has anticancer activity, but its effects on autophagy- and lysosome-related processes in breast cancer remain incompletely understood.  Methods: We evaluated the effects of BBM on MDA-MB-231, MDA-MB-468, MCF-7, and 4T1 breast cancer cells and normal mammary epithelial cells using assays of cell viability, migration, invasion, autophagy-related responses, lysosome-associated changes, immunofluorescence, transmission electron microscopy, and Western blotting. Exploratory network analysis was used to prioritize candidate BBM-associated pathways, and molecular docking was used to predict interactions between BBM and selected pathway proteins. Antitumor activity was further assessed in an MCF-7 xenograft model.  Results: BBM inhibited the proliferation, migration, and invasion of breast cancer cells while showing relatively low cytotoxicity toward normal mammary epithelial cells. BBM treatment was associated with increased levels of p-ULK1, ATG5, ATG7, and Beclin1, increased LC3 puncta, and accumulation of double-membraned autophagosomes. BBM was also associated with TFEB nuclear translocation, increased LAMP2 expression, and enhanced LysoTracker staining. Network analysis prioritized the PI3K/Akt signaling pathway, and molecular docking predicted potential interactions between BBM and PI3K, Akt1, and mTOR. Western blot analysis showed reduced phosphorylation of these proteins in cultured breast cancer cells. In the MCF-7 xenograft model, BBM inhibited tumor growth and was associated with changes in autophagy-related markers.  Discussion: These findings support the involvement of autophagy-related responses, lysosome-associated changes, and PI3K/Akt1/mTOR pathway modulation in the anti-breast-cancer effects of BBM, while further studies are needed to establish direct target engagement and causal relationships.
SN  - 1663-9812
ER  -